Recruitment

Eingeschlossene Patienten: 19.247 (Stand 04. Februar 2020)
Amgevita® (Adalimumab)	65
Benepali® (Etanercept)	653
Cimzia® (Certolizumab)	908
Enbrel® (Etanercept)	2860
Erelzi® (Etanercept)	234
Flixabi® (Infliximab)	3
Hulio® (Adalimumab)	19
Humira® (Adalimumab)	2905
Hyrimoz® (Adalimumab)	48
Idacio® (Adalimumab)	2
Imraldi® (Adalimumab)	68
Inflectra™ (Infliximab)	16
Kevzara® (Sarilumab)	117
Kineret® (Anakinra)	89
MabThera® (Rituximab)	1459
Olumiant® (Baricitinib)	355
Orencia® (Abatacept)	807
Remicade® (Infliximab)	762
Remsima® (Infliximab)	11
Rixathon® (Rituximab)	9
RoActemra® (Tocilizumab)	1326
Simponi® (Golimumab)	444
Xeljanz® (Tofacitinib)	277
Zessly® (Infliximab)	2
Kontrollen	5808